Point mutations in the dihydrofolate reductase-thymidylate synthase gene and pyrimethamine and cycloguanil resistance in Plasmodium falciparum
- 31 January 1995
- journal article
- research article
- Published by Elsevier in Molecular and Biochemical Parasitology
- Vol. 69 (1) , 135-138
- https://doi.org/10.1016/0166-6851(94)00207-4
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- In Vitro Activity of Pyrimethamine, Cycloguanil, and Other Antimalarial Drugs Against African Isolates and Clones of Plasmodium falciparumThe American Journal of Tropical Medicine and Hygiene, 1994
- In vitrosusceptibility of Cambodian isolates ofPlasmodium falciparumto halofantrine, pyronaridine and artemisinin derivativesPathogens and Global Health, 1994
- Prevalence of the Dihydrofolate Reductase Asn-108 Mutation as the Basis for Pyrimethamine-Resistant Falciparum Malaria in the Brazilian AmazonThe American Journal of Tropical Medicine and Hygiene, 1991
- Heterologous expression of active thymidylate synthase-dihydrofolate reductase from Plasmodium falciparumBiochemistry, 1990
- Point mutations in the dihydrofolate reductase-thymidylate synthase gene as the molecular basis for pyrimethamine resistance in Plasmodium falciparumMolecular and Biochemical Parasitology, 1989
- Characterisation of the dihydrofolate reductase-thymidylate synthetase gene from human malaria parasites highly resistant to pyrimethamineGene, 1989
- Plasmodium falciparum: Three amino acid changes in the dihydrofolate reductase of a pyrimethamine-resistant mutantExperimental Parasitology, 1988
- Plasmodium falciparum: Drug sensitivity in vitro of isolates before and after adaptation to continuous cultureExperimental Parasitology, 1983
- In Vitro Study of Drug Sensitivity of Plasmodium Falciparum: Evaluation of a New Semi-Micro TestThe American Journal of Tropical Medicine and Hygiene, 1983